The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation: mitral valve repair and mitral valve replacement.

Healthcare providers must reinforce their efforts to monitor and visualize dose levels from radiology examinations to enhance patient safety and meet new regulatory demands. There is also a need to justify and optimize the usage of radiation dose to find a balance between safer practice, image quality and lower dose – all for the benefit of the patient. Implementing tools for automatic and continuous follow up of radiation dose is at the forefront of meeting these challenges.

The radical increase in patient exposure to radiation from medical imaging over the last two decades has created great concerns about its inherent risks. Today, one of the highest priorities on many hospital agendas is to break this trend by achieving improved control of the radiation exposure to their patients.